期刊文献+

中国部分城市稳定期慢性阻塞性肺疾病治疗现况断面调查 被引量:29

The investigation of the treatment conditions in stable COPD patients in partial cities of China.
原文传递
导出
摘要 目的评估中国部分城市中稳定期慢性阻塞性肺疾病(COPD)患者治疗用药状况。方法由中国呼吸病专家咨询小组设计调查方案,采取横断面调查,2006年7月至10月在中国6大城市对258名呼吸科医师和723例稳定期COPD患者进行面对面调查。医生方面调查包括:首诊及复诊COPD处方用药情况,对现有药物的评价,药物治疗对稳定期COPD的作用及对COPD患者治疗依从性的评价;患者方面包括用药情况、用药类别、用药过程如何调整剂量及停药情况。结果所用药物中(包括医生问卷及患者问卷回答)排在第一位是祛痰剂,其次是β2受体激动剂,M胆碱能受体拮抗剂排在第四位。82%医生认为大多数COPD患者治疗依从性较好,但是实际上大约50%患者会自行减少用药,尤其是一旦病情缓解就停止用药。结论COPD患者用药中,M胆碱受体拮抗剂应用不够普遍,相反祛痰药应用较多。COPD患者用药治疗依从性仍旧较差,需要大力加强COPD的教育和管理。 Objective To investigate and assess the condition of used medicine in the patiests with stable COPD in partial cities in China. Methods 723 stable COPD patiests and 258 physicians of respiratory department were interviewed faceto-face in outpatients' departments in 6 large cities in China. The questionnaire of physician included the condition of prescription medicine on initial and subsequent visit, their assessment of used medicine, effects of medicine on the patients with stable COPD, as well as the assessment of the patients' compliance, in addition, the condition used medicine, the kinds of used drugs, how to adjust the dose of drugs and the conditions of drug-withdraud reported by patients themselves. Results During the used medicine, including the answers of both physician, and patients, mucolytic agents ware arranged the first, next, ~_-agonists, and yet anticholinergics in the fourth,82 percent of physicians considered that the patiest with COPDhad betler compliance, but, in fact, aboat 50 percent of patieats changed their pharmacologic treatmeat plan, even stoped the medicine, once their ill condition was improved or relieved. Conclusion Antieholinergics was not used widespread in treatment of COPD patients, on the contrary, more mucolytic agents were used,Moreover,the patients'eomplianee was relatively poor and needed to be improve.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2009年第4期354-357,共4页 Chinese Journal of Practical Internal Medicine
关键词 慢性阻塞性肺疾病 现况调查 β-受体拮抗剂 chronic obstructive pulmonary disease stable stage pharmacologic treatment medicine
  • 相关文献

参考文献10

  • 1慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2002,25(8):453-460. 被引量:5103
  • 2In chronic obstructive pulmonary disease, a combination of iprat- ropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group [ J ]. Chest, 1994,105 : 1411 - 1419.
  • 3Routine nebulized ipratropium and albuterol together are better than either alone in COPD. The COMBIVENT Inhalation Solution Study Group[ J ]. Chest, 1997,112 (6) : 1514 - 1521.
  • 4Gross N, Tashkin D, Miller R, et al. Inhalation by nebulization of albuterol-ipratropium combination (Dey combination)is superior to either agent alone in the treatment of chronic obstructive pulmonary disease. Dey Combination Solution Study Group [ J ]. Respiration, 1998,65:354 - 362.
  • 5Mahler DA, Wire P, Horstman D, et al. Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease[ J]. Am J Respir Crit Care Med,2002,166 : 1084 - 1091.
  • 6Calverley P, Pauwels R, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease : a randomized controlled trial [ J ]. Lancet, 2003,361 : 449 - 456.
  • 7Szafranski W, Cukier A, Ramirez A, et al. Effecacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease [ J ]. Eur Respir J, 2003,21 : 74 - 81.
  • 8Hanania NA, Darken P, Horstman D, et al. The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50mircog) combined in the Diskus inhaler for the treatment of COPD [ J ]. Chest,2003,124:834 - 843.
  • 9Calverley PM, Boonsawat W, Cseke Z, et al. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease[J]. Eur Respir J,2003,22(6) :912 -919.
  • 10Zheng JP, Kang J, Huang SG, et al. Effect of carbocisteine on a-cute exacerbation of chronic obstructive pulmonary disease ( PEACE Study ) : a randomised placebo-controlled study [ J ]. Lancet,2008,371 (9629) :2013 -2018.

共引文献5102

同被引文献220

引证文献29

二级引证文献2838

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部